Ping An Biomedical Statistics
Total Valuation
PASW has a market cap or net worth of $17.23 million. The enterprise value is $15.73 million.
| Market Cap | 17.23M |
| Enterprise Value | 15.73M |
Important Dates
The last earnings date was Friday, August 7, 2026, after market close.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PASW has 124.55 million shares outstanding. The number of shares has increased by 93.03% in one year.
| Current Share Class | 124.55M |
| Shares Outstanding | 124.55M |
| Shares Change (YoY) | +93.03% |
| Shares Change (QoQ) | +5.33% |
| Owned by Insiders (%) | 9.84% |
| Owned by Institutions (%) | 0.24% |
| Float | 97.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.37 |
| Forward PS | n/a |
| PB Ratio | 1.49 |
| P/TBV Ratio | 1.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.96 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.54, with a Debt / Equity ratio of 0.13.
| Current Ratio | 2.54 |
| Quick Ratio | 1.21 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -36.66 |
Financial Efficiency
Return on equity (ROE) is -11.35% and return on invested capital (ROIC) is -15.54%.
| Return on Equity (ROE) | -11.35% |
| Return on Assets (ROA) | -8.86% |
| Return on Invested Capital (ROIC) | -15.54% |
| Return on Capital Employed (ROCE) | -13.49% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $528,382 |
| Profits Per Employee | -$78,086 |
| Employee Count | 7 |
| Asset Turnover | 0.34 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -129,430 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.94% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -88.94% |
| 50-Day Moving Average | 0.13 |
| 200-Day Moving Average | 0.21 |
| Relative Strength Index (RSI) | 50.53 |
| Average Volume (20 Days) | 19,007,994 |
Short Selling Information
The latest short interest is 46,891, so 0.04% of the outstanding shares have been sold short.
| Short Interest | 46,891 |
| Short Previous Month | 110,041 |
| Short % of Shares Out | 0.04% |
| Short % of Float | 0.05% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PASW had revenue of $3.70 million and -$546,599 in losses. Loss per share was -$0.02.
| Revenue | 3.70M |
| Gross Profit | 342,909 |
| Operating Income | -1.53M |
| Pretax Income | -676,030 |
| Net Income | -546,599 |
| EBITDA | -1.53M |
| EBIT | -1.53M |
| Loss Per Share | -$0.02 |
Balance Sheet
The company has $2.98 million in cash and $1.49 million in debt, with a net cash position of $1.49 million or $0.01 per share.
| Cash & Cash Equivalents | 2.98M |
| Total Debt | 1.49M |
| Net Cash | 1.49M |
| Net Cash Per Share | $0.01 |
| Equity (Book Value) | 11.34M |
| Book Value Per Share | 0.09 |
| Working Capital | 4.91M |
Cash Flow
| Operating Cash Flow | -826,436 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 730 |
| Net Borrowing | -5.32M |
| Free Cash Flow | -826,436 |
| FCF Per Share | -$0.01 |
Margins
Gross margin is 9.27%, with operating and profit margins of -41.34% and -14.78%.
| Gross Margin | 9.27% |
| Operating Margin | -41.34% |
| Pretax Margin | -18.28% |
| Profit Margin | -14.78% |
| EBITDA Margin | -41.32% |
| EBIT Margin | -41.34% |
| FCF Margin | n/a |
Dividends & Yields
PASW does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -93.03% |
| Shareholder Yield | -93.03% |
| Earnings Yield | -3.38% |
| FCF Yield | -5.12% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |